Skip to content
Home/Companies/Biotech/Sanifit Therapeutics

Sanifit Therapeutics

Biotech·Spain·Exited 2021·Held 2yr
Entry
2019
Hold
2yr
Exit
2021

Who owns Sanifit Therapeutics?

Sanifit Therapeutics was owned by Columbus Venture Partners through Columbus Life Science Fund II (2019 vintage) from 2019 to 2021, exited via Trade Sale. Across its history, Sanifit Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Columbus Venture Partners
Most recent investor
Columbus Venture Partners
Columbus Life Science Fund II · 2019 · Life Sciences VC
4 ownership periods · full history below

Key facts

HQSpain
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2021.
  • ·Average hold across 4 realized cycles: 7 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Exited
Last exited in 2021 to .
Co-invest · 4 holders · 2006 · 2021
Caixa Capital Risc
2006 · 2021(15yr) · Criteria Bio Ventures · 2002 · VC
Trade Sale · to
MOIC
Invivo Partners
Invivo PartnersExited 2021
2014 · 2021(7yr) · Healthequity · 2012 · Life Sciences VC
Trade Sale · to
MOIC
Columbus Venture Partners
2019 · 2021(2yr) · Columbus Life Science Fund II · 2019 · Life Sciences VC
Trade Sale · to
MOIC
Alta Life Sciences
2019 · 2021(2yr) · Alta Life Sciences Spain I FCR · 2016 · Life Sciences VC
Trade Sale · to
MOIC
Track Sanifit Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Sanifit Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue